ADAMS R MARK has filed 8 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 817 shares of Adaptive Biotechnologies Corp ($ADPT) on April 10, 2023.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 10, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 817 | $8.50 | 177,669.0000 | 142,515,917 | 0.46% | 0.00% |
| April 11, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 2308 | $8.63 | 175,361.0000 | 142,515,917 | 1.30% | 0.00% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | A | Common Stock | 88652 | $0.00 | 202,170.0000 | 142,515,917 | 78.10% | 0.06% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 6529 | $8.57 | 195,641.0000 | 142,515,917 | 3.23% | 0.00% |
| March 7, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 17155 | $8.60 | 178,486.0000 | 142,515,917 | 8.77% | 0.01% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | A | Stock Option (right to buy) | 133033 | $0.00 | 133,033.0000 | 142,515,917 | 9999.99% | 0.09% |
| Jan. 9, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 995 | $8.50 | 115,648.0000 | 142,515,917 | 0.85% | 0.00% |
| Jan. 10, 2023 | Adaptive Biotechnologies Corp | $ADPT | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 2130 | $8.58 | 113,518.0000 | 142,515,917 | 1.84% | 0.00% |